Tuesday, May 18, 2021
Re: [IAC#RG] Another fake COVID-19 drug gets approval from CORRUPT DCGI
Dear Lt. Col (Retd) Dalvi
My sincere apologies for cross posting the HRA's confidential Bill Gates dossier to this list inadvertently.
I must congratulate Team HRA for the wonderful job the HRA members are doing silently, thanklessly and out of the media / social media gaze.
However, seeing the responses from this list to your revelations, it is akin to your casting pearls before swine.
Swapnil
On Mon, May 17, 2021 at 8:28 AM Rajinder Dalvi <indiaresists@lists.riseup.net> wrote:
Dear Ms. Kotwal and Dr. Rajan
Although the 2-DG molecules have been used extensively for cancer treatment it still lacks approval from the regulators as an anti-cancer drug for the reason that the 2-DG's theory of glycolysis inhibition destroying malignant cells is still unproven on humans.It is well known by now, the the DRDO is a completely useless body packed with the most stupid and otherwise unemployable scientists ever assembled in one organsiation. No private company worth the name would hire these DRDO morons, Patanjali being the notable exception so as to tomtom that Baba-no-Swami-no-Rishi Ramdev (or his homosexual buddy) invented 2-DG.Dr. Rajan does a great disservice to our members by not linking to the Hindu article he referred to which exposed 2-DG is a FAKE DRUG,There is also no doubt that 2-DG is a FAKE DRUG for COVID treatment, and it's as fake as that Nepali billionaire "inter"-fail rogue "Acharya" Balkrishna's medical / research qualifications are.From these kinds of dubious approvals, it is also undeniable that present DCGI Dr. V.G Somani (probably a Gujarati like the rest of Modi's key appointees) is a corrupt and pliable rubber stamp Drugs regulator, handpicked by Modi to carry out the final scams of a Govt on its way out.NB: Anyone promoting fake COVID drugs / cures / quacks on this mailing list will be unsubscribed without notice.RS DalviList AdministratorCamp: Germany (Europe)
Monday, May 17, 2021
Re: [IAC#RG] Some good news on vaccine front
You, believing that a virtually illiterate10th fail Nepali called Balkrishna invented a 4 decade old medicine, are hardly the person qualified to talk about Western system vaccines. Please go and take CORONIL instead like millions of bloody fool Indians are doing.
On Tue, May 18, 2021 at 12:02 PM Pankaj Jangid <pankaj@codeisgreat.org> wrote:
"Bikash Bhattacharya" (via indiaresists Mailing List)
<indiaresists-3hfIC0tI0F+k/GrYEfjPQg@public.gmane.org> writes:
> FYI, These *COVISHIELD vaccines were rejected in USA*
> <https://www.fiercepharma.com/pharma/fda-could-reject-astra-zeneca-s-covid-vaccine-efficacy-and-manufacturing-shortfalls-analyst>
> because they don't work too well on the new more aggressive variants
> ...
This is opposite of what I have read till now about mRNA vaccines. I
have read that the mRNA vaccine is not effective for new variants and
they will release a new booster dose for each new variant or a set of
variants.
Could you please clarify, Mr. Bikash, if my understanding is wrong?
--
Regards,
Pankaj Jangid
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in
Re: [IAC#RG] Some good news on vaccine front
Dear Brother Prakash
As per the current information, the Indian variant B.1.617.1 is 6-8 times more resistant to vaccines than the standard SARS-CoV-2 original strains of first wave. So all vaccines are comparatively much less effective against it. As India's experience of fully inoculated persons dying from Covid shows, COVISHIELD vaccine, especially, is virtually useless against the Indian strain.https://www.news-medical.net/news/20210512/mRNA-based-COVID-19-vaccines-are-effective-against-Indian-SARS-CoV-2-variant-says-study.aspx
Compared to previously circulating SARS-CoV-2 variants, the B.1.617.1 variant contains multiple mutations in specific spike regions, including the N-terminal antigenic supersite, the receptor-binding domain (RBD), and the polybasic furin cleavage site at the S1/S2 boundary...
Compared to the wildtype virus, the B.1.617.1 variant is significantly resistant (6.8-fold) to neutralization by antibodies developed in response to natural infection or vaccination. Despite such lower sensitivity, about 79% of convalescent sera and 100% of vaccinated sera showed considerable effectiveness in neutralizing the B.1.617.1 variant.
Taken together, the study highlights the effectiveness of mRNA-based COVID-19 vaccines in inducing neutralizing antibodies against newly emerging SARS-CoV-2 variants like B.1.617.1.
However, WHO has a different take on the same study, which is available as a pre-print.
This is all academic, because India cannot afford such expensive vaccines and we must make do with what we can afford, ie. COVISHIELD and COVAXIN, even if the former is useless.
On Tue, May 18, 2021 at 12:02 PM Pankaj Jangid <pankaj@codeisgreat.org> wrote:
"Bikash Bhattacharya" (via indiaresists Mailing List)
<indiaresists-3hfIC0tI0F+k/GrYEfjPQg@public.gmane.org> writes:
> FYI, These *COVISHIELD vaccines were rejected in USA*
> <https://www.fiercepharma.com/pharma/fda-could-reject-astra-zeneca-s-covid-vaccine-efficacy-and-manufacturing-shortfalls-analyst>
> because they don't work too well on the new more aggressive variants
> ...
This is opposite of what I have read till now about mRNA vaccines. I
have read that the mRNA vaccine is not effective for new variants and
they will release a new booster dose for each new variant or a set of
variants.
Could you please clarify, Mr. Bikash, if my understanding is wrong?
--
Regards,
Pankaj Jangid
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in
Re: [IAC#RG] Some good news on vaccine front
"Bikash Bhattacharya" (via indiaresists Mailing List)
<indiaresists-3hfIC0tI0F+k/GrYEfjPQg@public.gmane.org> writes:
> FYI, These *COVISHIELD vaccines were rejected in USA*
> <https://www.fiercepharma.com/pharma/fda-could-reject-astra-zeneca-s-covid-vaccine-efficacy-and-manufacturing-shortfalls-analyst>
> because they don't work too well on the new more aggressive variants
> ...
This is opposite of what I have read till now about mRNA vaccines. I
have read that the mRNA vaccine is not effective for new variants and
they will release a new booster dose for each new variant or a set of
variants.
Could you please clarify, Mr. Bikash, if my understanding is wrong?
--
Regards,
Pankaj Jangid
<indiaresists-3hfIC0tI0F+k/GrYEfjPQg@public.gmane.org> writes:
> FYI, These *COVISHIELD vaccines were rejected in USA*
> <https://www.fiercepharma.com/pharma/fda-could-reject-astra-zeneca-s-covid-vaccine-efficacy-and-manufacturing-shortfalls-analyst>
> because they don't work too well on the new more aggressive variants
> ...
This is opposite of what I have read till now about mRNA vaccines. I
have read that the mRNA vaccine is not effective for new variants and
they will release a new booster dose for each new variant or a set of
variants.
Could you please clarify, Mr. Bikash, if my understanding is wrong?
--
Regards,
Pankaj Jangid
[IAC#RG] Chaos is necessary to the birth of a news star
Comrades,
The HRA manifesto began with Nietzche's phrase Chaos is necessary to the birth of a new star, which was also incorporated into IAC's 2013 manifesto, with the approval of all those present here today, in the section for surgical strikes against Hindustan's enemies,
In the past 7 years the times for homeopathic remedies have come and gone, as has also those for allopathic remedies described in our manifesto.
Re: [IAC#RG] Some good news on vaccine front
Dear Friend
There is nothing wrong with these COVISHIELD vaccines which would otherwise go stale in the USA in 2 or 3 months.
There is nothing wrong with these COVISHIELD vaccines which would otherwise go stale in the USA in 2 or 3 months.
FYI, These COVISHIELD vaccines were rejected in USA because they don't work too well on the new more aggressive variants and also their efficiency is around 50% per dose as compared to 90% plus of USA mRNA vaccines like Pfizers and Moderna. So whereas in a 2 dose combination the COVISHILED can theoretically achieve 75% safety the USA vaccines will achieve 99.3% safety. However the USA vaccines are 5 times the cost of COVISHIELD so it is a simple management decision for poor country like India to go for COVISHIELD option considering the precarious economy (we are about to be declared as JUNK bond) by rating agencies) and the vast population to be innoculated so they can eke out their living in absence of state support and social security.
In simple language, "Beggars cannot be choosers".
Bikash Bhattacharya
Member Covid Task Force
Laghu Udyog Bharti (WB)
On Mon, May 17, 2021 at 5:55 PM ヴィカス ヤダヴァ (vikas yadav) <indiaresists@lists.riseup.net> wrote:
Anyone knows why "rejected for use in the USA"?On Mon, 17 May 2021, 15:47 Sandeep Nagpal, <indiaresists@lists.riseup.net> wrote:A very good strategy to make (secret) profits... export price of USD 3.75 and reimport price of USD 11.83...On Mon, May 17, 2021 at 4:51 AM Bikash Bhattacharya <indiaresists@lists.riseup.net> wrote:This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.FriendsThe prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.
Finally, a good news on the vaccine front.
The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.Bikash BhattacharyaMember Covid Task ForceLaghu Udyog Bharti (WB)
Subscribe to:
Posts (Atom)
